Cargando…
Potential of Interferon Lambda as an Inhibitor of SARS-CoV-2
This study provides an overview of scientific results on the feasibility of using type III interferons against SARS-CoV-2. We have analyzed data obtained from the PubMed electronic database for the period 2020‒2022. The results of our own studies of pharmacological substances based on recombinant IF...
Autores principales: | Oleinik, L. A., Madonov, P. G., Pykhtina, M. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131541/ https://www.ncbi.nlm.nih.gov/pubmed/37128210 http://dx.doi.org/10.1134/S0026893323020152 |
Ejemplares similares
-
Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2
por: Madonov, P. G., et al.
Publicado: (2021) -
The Structure and Function of the DNA from Bacteriophage Lambda
por: Hogness, David S.
Publicado: (1966) -
DNA damage recognition /
Publicado: (2006) -
On the Internal Structure of Bacteriophage Lambda
por: Kaiser, A. D.
Publicado: (1966) -
Increased LAMP1 Expression Enhances SARS-CoV-1 and SARS-CoV-2 Production in Vero-Derived Transgenic Cell Lines
por: Dolskiy, A. A., et al.
Publicado: (2022)